Prevention of progression of kidney disease - CARI guidelines
Johnson, D.W.
Australian Family Physician 36(5): 353
2007
ISSN/ISBN: 0300-8495 PMID: 17492072 Document Number: 613876
The CARI guidelines initiative is an Australia/New Zealand project that aims to provide high quality, evidence based clinical practice guidelines for the management of all stages of kidney disease. This article summarises the CARI guidelines on Prevention of progression of kidney disease: diet and miscellaneous factors. Complete CARI guideline detail is available at the web site.
Document emailed within 1 workday
Related Documents
Nicholls, K. 2007: Prevention of progression of kidney disease: diabetic nephropathy - CARI guidelines Australian Family Physician 36(3): 137-138Voss, D.; Hodson, E.; Crompton, C. 2007: Nutrition and growth in kidney disease: CARI guidelines Australian Family Physician 36(4): 253-254
Kes, P.; Slavicek, J. 2013: Hepatitis C virus and chronic progressive kidney disease. Guidelines for detection, evaluation, treatment and prevention of infection transmission in hemodialysis units; procedure for infected patients-candidates for kidney transplantation and procedure for patients suspected of HCV infection-related kidney disease Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 67(4): 361-366
Bodick, N.; Forette, F.; Hadler, D.; Harvey, R.J.; Leber, P.; McKeith, I.G.; Riekkinen, P.J.; Rossor, M.N.; Scheltens, P.; Shimohama, S.; Spiegel, R.; Tanaka, S.; Thal, L.J.; Urata, Y.; Whitehouse, P.; Wilcock, G. 1997: Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group Alzheimer Disease and Associated Disorders 11 Suppl. 3: 50-53
Stanley, M.; Kelly, J.; Harris, D. 2007: Acceptance onto dialysis - CARI guidelines Australian Family Physician 36(6): 439
Devuyst, O. 2003: Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide? Journal of Nephrology 16(3): 449-452
Simoons, M.L.; Vos, J.; Deckers, J.W.; de Feyter, P.J. 1995: Coronary artery disease: prevention of progression and prevention of events European Heart Journal 16(6): 729-733
Sukmark, T.; Sukmark, S. 2014: Predictors of faster progression in chronic kidney disease Journal of the Medical Association of Thailand 97(8): 812-819
Putri, A.Y.; Thaha, M. 2014: Role of oxidative stress on chronic kidney disease progression Acta Medica Indonesiana 46(3): 244-252
Johnson, C.Ann.; Levey, A.S.; Coresh, J.; Levin, A.; Lau, J.; Eknoyan, G. 2004: Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors American family physician 70(5): 869-876
Pettilä, V.; Halme, L.; Hanski, M.; Honkanen, E.; Laukkanen, A.; Metsärinne, K.; Peltonen, S.; Puurunen, M.; Uusaro, A.; Wuorela, M. 2009: Update on current care guidelines. Prevention and treatment of acute kidney injury in adults Duodecim; Laaketieteellinen Aikakauskirja 125(20): 2236-2237
Orisio, S.; Zoja, C.; Remuzzi, G. 1993: The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 8(4): 213-217
Jaguś, D.; Wojtaszek, E. 2017: Vaccination in chronic kidney disease - guidelines and evidence Wiadomosci Lekarskie 70(6 Pt 2): 1179-1184
Torres, V.E. 1996: Polycystic kidney disease: guidelines for family physicians American Family Physician 53(3): 847
Ruperto López, M.; Barril Cuadrado, G.; Lorenzo Sellares, V. 2008: Nutrition guidelines for advanced chronic kidney disease (ACKD) Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28 Suppl. 3: 79-86
Perepanova, T.S. 2016: The 2015 Federal Clinical Guidelines for Antimicrobial Therapy and Prevention of Infections of the Kidney, Urinary Tract, and Male Genitals Terapevticheskii Arkhiv 88(4): 100-104
Verdalles, U.; García de Vinuesa, S.; Goicoechea, M.; Gómez Campderá, F.; Luño, J. 2007: Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD) Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(3): 320-328
2000: 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part III. Prevention of disease recurrence. United States Public Health Service/Infectious Diseases Society of America American Family Physician 61(3): 771-8 780 785
Masur, H.; Brooks, J.T.; Benson, C.A.; Holmes, K.K.; Pau, A.K.; Kaplan, J.E. 2014: Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 58(9): 1308-1311
Panawong, W.; Chaiyakum, A.; Pongskul, C. 2011: Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease Journal of the Medical Association of Thailand 94(10): 1175-1183